DYNAMICURE Trademark

Trademark Overview

On Thursday, September 19, 2019, a trademark application was filed for DYNAMICURE with the United States Patent and Trademark Office. The USPTO has given the DYNAMICURE trademark a serial number of 88622674. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2024. This trademark is owned by DynamiCure Biotechnology, LLC. The DYNAMICURE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders, all of the foregoing excluding treatments for neuromuscular disorders and orphan diseases

Research and development services in the field of biologics, namely, antibodies and peptides for the treatment of cancer and immunotherapies; research and development in the pharmaceutical and biotechnology fields for the treatment of cancer and immunotherapies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of cancer and immunotherapies; consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics in the field of cancer and immunotherapies; conducting research for others in the field of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics in the field of cancer and immunotherapies
dynamicure

General Information

Serial Number88622674
Word MarkDYNAMICURE
Filing DateThursday, September 19, 2019
Status700 - REGISTERED
Status DateTuesday, May 7, 2024
Registration Number7380913
Registration DateTuesday, May 7, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of oncological diseases and disorders, all of the foregoing excluding treatments for neuromuscular disorders and orphan diseases
Goods and ServicesResearch and development services in the field of biologics, namely, antibodies and peptides for the treatment of cancer and immunotherapies; research and development in the pharmaceutical and biotechnology fields for the treatment of cancer and immunotherapies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of cancer and immunotherapies; consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics in the field of cancer and immunotherapies; conducting research for others in the field of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics in the field of cancer and immunotherapies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2019
Primary Code005
First Use Anywhere DateSunday, December 31, 2023
First Use In Commerce DateSunday, December 31, 2023
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 25, 2019
Primary Code042
First Use Anywhere DateSunday, December 31, 2023
First Use In Commerce DateSunday, December 31, 2023

Trademark Owner History

Party NameDynamiCure Biotechnology, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWaltham, MA 02451
Party NameDynamiCure Biotechnology, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142
Party NameDynamiCure Biotechnology, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, September 23, 2019NEW APPLICATION ENTERED
Wednesday, September 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 19, 2019ASSIGNED TO EXAMINER
Friday, December 20, 2019NON-FINAL ACTION WRITTEN
Friday, December 20, 2019NON-FINAL ACTION E-MAILED
Friday, December 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Tuesday, March 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 20, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 2, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, July 26, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, July 26, 2021AMENDMENT AFTER NOA NOT ENTERED
Friday, August 6, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 9, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 9, 2021SOU EXTENSION 1 FILED
Thursday, September 9, 2021SOU EXTENSION 1 GRANTED
Saturday, September 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 9, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 9, 2022SOU EXTENSION 2 FILED
Wednesday, March 9, 2022SOU EXTENSION 2 GRANTED
Friday, March 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 9, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 9, 2022SOU EXTENSION 3 FILED
Friday, September 9, 2022SOU EXTENSION 3 GRANTED
Tuesday, September 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 7, 2023SOU EXTENSION 4 FILED
Tuesday, March 7, 2023SOU EXTENSION 4 GRANTED
Thursday, March 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 6, 2023SOU EXTENSION 5 FILED
Tuesday, September 12, 2023SOU EXTENSION 5 GRANTED
Saturday, March 9, 2024USE AMENDMENT FILED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 7, 2024REGISTERED-PRINCIPAL REGISTER
Saturday, March 9, 2024TEAS STATEMENT OF USE RECEIVED
Monday, March 18, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 2, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 3, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 26, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 26, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 26, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 26, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 26, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 7, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

dynamicure field research cancer immunotherapies pharmaceutical development biotechnology treatment fields disorders